Deleting a Serotonin Receptor Reduced THC Memory Effects at One Mouse Dose, Not Both
Deleting the serotonin 5-HT2A receptor reduced a THC-related memory effect in mice at 3 mg/kg but not at 10 mg/kg. The dose-dependent result limits claims that removing one receptor universally prevents THC’s cognitive effects.
Mechanistic animal and cell research
Researchers compared mice lacking 5-HT2A receptors with wild-type mice. Cell experiments, brain-tissue methods and pharmacological interventions examined interactions between cannabinoid CB1 and serotonin receptors.
The memory experiment used novel-object recognition. It measured mouse behavior under specified conditions, not human testimony, driving or a clinical memory diagnosis.
The higher-dose result belongs beside the rescue
THC impaired object-recognition performance in wild-type mice at both doses. Receptor deletion significantly reduced the impairment at 3 mg/kg, but that protection was not demonstrated at 10 mg/kg.
The authors interpreted this as evidence that the receptor interaction influences THC’s potency for this effect. It does not establish the receptor as the only pathway capable of producing a deficit at every exposure.
Other responses did not disappear together
Movement suppression, hypothermia and antinociceptive responses were not abolished by the genetic deletion. THC’s different effects should not be treated as one indivisible intoxication score.
Cell and brain experiments supported formation and functional interaction of CB1–5-HT2A receptor complexes. Engineered-cell signaling and mouse behavior are different evidence types; neither is a demonstrated human treatment.
A knockout is not a clinical antidote
Lifelong receptor deletion is not equivalent to administering a receptor-blocking medicine. Developmental compensation, route and dose can affect translation. Additional interference-peptide experiments likewise do not establish routine clinical use.
The useful boundary is the absent protection at the higher dose: a mechanistic finding can be real while failing to explain or prevent the full range of THC effects.
For the separate drug-development question, see our analysis of a later peptide experiment targeting the receptor interaction.
Primary research
Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors. PLoS Biology (2015). DOI: 10.1371/journal.pbio.1002194.
